CA Stock MarketDetailed Quotes

NRX NurExone Biologic Inc

Watchlist
  • 0.710
  • 0.0000.00%
15min DelayMarket Closed Nov 29 16:00 ET
50.30MMarket Cap-6761P/E (TTM)

NurExone Biologic Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
24.53%1.32M
27.96%920K
-34.00%3.66M
-14.86%716K
17.81%1.16M
-28.57%1.06M
-67.73%719K
223.47%5.54M
-6.97%841K
263.24%988K
Selling and administrative expenses
34.66%812K
101.45%695K
-49.35%2.1M
-12.67%386K
34.63%762K
-48.94%603K
-82.28%345K
262.81%4.14M
-27.18%442K
142.92%566K
-General and administrative expense
34.66%812K
101.45%695K
-49.35%2.1M
-12.67%386K
34.63%762K
-48.94%603K
-82.28%345K
262.81%4.14M
-27.18%442K
142.92%566K
Research and development costs
11.16%508K
-39.84%225K
10.78%1.54M
-19.74%309K
-4.74%402K
50.83%457K
33.10%374K
142.76%1.39M
29.63%385K
982.05%422K
Depreciation amortization depletion
----
----
50.00%21K
----
----
----
----
--14K
----
----
-Depreciation and amortization
----
----
50.00%21K
----
----
----
----
--14K
----
----
Operating profit
-24.53%-1.32M
-27.96%-920K
34.00%-3.66M
14.86%-716K
-17.81%-1.16M
28.57%-1.06M
67.73%-719K
-223.47%-5.54M
6.97%-841K
-263.24%-988K
Net non-operating interest income (expenses)
-125.00%-5K
-114.29%-2K
333.33%42K
-99.16%3K
142.86%6K
107.25%20K
116.09%14K
-38.46%-18K
548.75%359K
-275.00%-14K
Non-operating interest income
-38.46%16K
----
----
----
----
--26K
----
----
----
----
Non-operating interest expense
250.00%21K
----
-90.91%3K
----
----
--6K
----
175.00%33K
----
----
Total other finance cost
----
114.29%2K
-200.00%-45K
98.47%-6K
-142.86%-6K
----
-116.09%-14K
-1,600.00%-15K
-676.47%-392K
275.00%14K
Other net income (expenses)
99.08%-24K
-3,403.80%-2.61M
-532K
-39K
Gain on sale of security
----
----
99.57%-2K
----
----
----
----
-689.87%-466K
----
----
Special income (charges)
----
----
--0
--0
--0
----
----
---2.08M
--0
---39K
-Less:Restructuring and mergern&acquisition
----
----
--0
--0
--0
----
----
--2.08M
--0
--39K
Other non-operating income (expenses)
----
----
66.67%-22K
----
----
----
----
---66K
----
----
Income before tax
-27.40%-1.33M
-30.78%-922K
55.45%-3.64M
27.32%-737K
-11.24%-1.16M
72.62%-1.04M
69.55%-705K
-395.99%-8.17M
-12.04%-1.01M
-294.32%-1.04M
Income tax
Earnings from equity interest net of tax
Net income
-27.40%-1.33M
-30.78%-922K
55.45%-3.64M
27.32%-737K
-11.24%-1.16M
72.62%-1.04M
69.55%-705K
-395.99%-8.17M
-12.04%-1.01M
-294.32%-1.04M
Net income continuous operations
-27.40%-1.33M
-30.78%-922K
55.45%-3.64M
27.32%-737K
-11.24%-1.16M
72.62%-1.04M
69.55%-705K
-395.99%-8.17M
-12.04%-1.01M
-294.32%-1.04M
Noncontrolling interests
Net income attributable to the company
-27.40%-1.33M
-30.78%-922K
55.45%-3.64M
27.32%-737K
-11.24%-1.16M
72.62%-1.04M
69.55%-705K
-395.99%-8.17M
-12.04%-1.01M
-294.32%-1.04M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-27.40%-1.33M
-30.78%-922K
55.45%-3.64M
27.32%-737K
-11.24%-1.16M
72.62%-1.04M
69.55%-705K
-395.99%-8.17M
-12.04%-1.01M
-294.32%-1.04M
Diluted earnings per share
8.33%-0.022
0.00%-0.016
62.50%-0.081
0.00%-0.015
13.33%-0.026
79.31%-0.024
70.71%-0.016
-455.86%-0.216
29.75%-0.015
-381.62%-0.03
Basic earnings per share
8.33%-0.022
0.00%-0.016
62.50%-0.081
0.00%-0.015
13.33%-0.026
79.31%-0.024
70.71%-0.016
-455.86%-0.216
29.75%-0.015
-381.62%-0.03
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 24.53%1.32M27.96%920K-34.00%3.66M-14.86%716K17.81%1.16M-28.57%1.06M-67.73%719K223.47%5.54M-6.97%841K263.24%988K
Selling and administrative expenses 34.66%812K101.45%695K-49.35%2.1M-12.67%386K34.63%762K-48.94%603K-82.28%345K262.81%4.14M-27.18%442K142.92%566K
-General and administrative expense 34.66%812K101.45%695K-49.35%2.1M-12.67%386K34.63%762K-48.94%603K-82.28%345K262.81%4.14M-27.18%442K142.92%566K
Research and development costs 11.16%508K-39.84%225K10.78%1.54M-19.74%309K-4.74%402K50.83%457K33.10%374K142.76%1.39M29.63%385K982.05%422K
Depreciation amortization depletion --------50.00%21K------------------14K--------
-Depreciation and amortization --------50.00%21K------------------14K--------
Operating profit -24.53%-1.32M-27.96%-920K34.00%-3.66M14.86%-716K-17.81%-1.16M28.57%-1.06M67.73%-719K-223.47%-5.54M6.97%-841K-263.24%-988K
Net non-operating interest income (expenses) -125.00%-5K-114.29%-2K333.33%42K-99.16%3K142.86%6K107.25%20K116.09%14K-38.46%-18K548.75%359K-275.00%-14K
Non-operating interest income -38.46%16K------------------26K----------------
Non-operating interest expense 250.00%21K-----90.91%3K----------6K----175.00%33K--------
Total other finance cost ----114.29%2K-200.00%-45K98.47%-6K-142.86%-6K-----116.09%-14K-1,600.00%-15K-676.47%-392K275.00%14K
Other net income (expenses) 99.08%-24K-3,403.80%-2.61M-532K-39K
Gain on sale of security --------99.57%-2K-----------------689.87%-466K--------
Special income (charges) ----------0--0--0-----------2.08M--0---39K
-Less:Restructuring and mergern&acquisition ----------0--0--0----------2.08M--0--39K
Other non-operating income (expenses) --------66.67%-22K-------------------66K--------
Income before tax -27.40%-1.33M-30.78%-922K55.45%-3.64M27.32%-737K-11.24%-1.16M72.62%-1.04M69.55%-705K-395.99%-8.17M-12.04%-1.01M-294.32%-1.04M
Income tax
Earnings from equity interest net of tax
Net income -27.40%-1.33M-30.78%-922K55.45%-3.64M27.32%-737K-11.24%-1.16M72.62%-1.04M69.55%-705K-395.99%-8.17M-12.04%-1.01M-294.32%-1.04M
Net income continuous operations -27.40%-1.33M-30.78%-922K55.45%-3.64M27.32%-737K-11.24%-1.16M72.62%-1.04M69.55%-705K-395.99%-8.17M-12.04%-1.01M-294.32%-1.04M
Noncontrolling interests
Net income attributable to the company -27.40%-1.33M-30.78%-922K55.45%-3.64M27.32%-737K-11.24%-1.16M72.62%-1.04M69.55%-705K-395.99%-8.17M-12.04%-1.01M-294.32%-1.04M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -27.40%-1.33M-30.78%-922K55.45%-3.64M27.32%-737K-11.24%-1.16M72.62%-1.04M69.55%-705K-395.99%-8.17M-12.04%-1.01M-294.32%-1.04M
Diluted earnings per share 8.33%-0.0220.00%-0.01662.50%-0.0810.00%-0.01513.33%-0.02679.31%-0.02470.71%-0.016-455.86%-0.21629.75%-0.015-381.62%-0.03
Basic earnings per share 8.33%-0.0220.00%-0.01662.50%-0.0810.00%-0.01513.33%-0.02679.31%-0.02470.71%-0.016-455.86%-0.21629.75%-0.015-381.62%-0.03
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data